Communicable Disease Investigation Reference Manual

Table of Contents

1.0  Introduction

(Revised 8/13)

2.0  Map - Districts for Statewide Disease Investigation/Terrorism Response/TB Control

(Updated 8/13)

3.0  Surveillance Systems

(Revised 8/08)

4.0  Diseases or Conditions

    Anaplasmosis

(New 4/08)

    Animal Bites / Injuries

(New 7/03)

    Anthrax

(Revised 2/11)

    Botulism

(Revised 12/13)

    Brucellosis

(Revised 10/13)

    Campylobacteriosis

(Revised 4/12)

    Chancroid

(New 7/03)

    Chlamydia Trachomatis

(New 7/03)

    Cholera

(Updated 4/12)

    Coccidioidomycosis

(Revised 1/12)

    Creutzfeldt-Jakob Disease

(Revised 5/05)

    Cryptosporidiosis

(Revised 8/11)

    Cyclosporiasis

(Revised 10/11)

    Dengue

(New 9/14)

    Diphtheria

(Updated 3/12)

    Escherichia coli O157:H7/Other Hemorrhagic E. coli

(Revised 6/11)

    Ehrlichiosis

(Revised 4/08)

    Encephalitis, Arboviral

(Revised 7/03)

        Eastern Equine

        Western Equine

        California Group

        West Nile

        St. Louis

    Giardiasis

(Revised 2/14)

    Glanders

(Updated 3/12)

    Gonorrhea

(New 7/03)

    Haemophilus influenzae, Invasive

(Revised 2/14)

    Hansen's Disease (Leprosy)

(Revised 4/12)

    Hantavirus Pulmonary Syndrome

(Updated 7/03)

    Hemolytic Uremic Syndrome (HUS), post-diarrheal

(Revised 6/11)

    Hemorrhagic Fevers (Viral)

(Revised 8/14)

         Arenaviridae: South American Hemorrhagic Viral Fevers (New World Arenaviruses)

         Arenaviridae: Lassa Fever (Old World Arenavirus)

         Bunyaviridae: Crimean-Congo Hemorrhagic Fever

         Filoviridae: Ebola Hemorrhagic Fever

         Filoviridae: Marburg Hemorrhagic Fever

    Hepatitis A

(Revised 11/13)

    Hepatitis B, acute/Delta Hepatitis

(Revised 7/08)

    Hepatitis C

(Revised 6/08)

    HIV/AIDS

(New 7/03)

    Influenza

(Updated 9/09)

    Latent Tuberculosis Infection

(Revised 3/14)

    Legionellosis

(Revised 12/13)

    Leptospirosis

(Updated 7/03)

    Listeriosis

(Updated 1/14)

    Lyme-like Disease

(Revised 5/08)

    Malaria

(Revised 3/14)

    Measles

(Updated 8/13)

    Meningococcal Disease

(Revised 9/14)

    Methicillin–resistant Staphylococcus aureus (MRSA)

(New 5/11)

    MOTT

(New 7/03)

    Mumps

(Revised 8/13)

    Outbreak Investigation

(Revised 7/14)

    Other Sexually Transmitted Diseases

(New 7/03)

          Nongonococcal Urethritis

          Mucopurulent Cervicitis

          Bacterial Vaginosis

          Trichomonal Vaginosis

          Vulvovaginal Candidiasis

          Genital Herpes

          Lymphogranuloma Venereum

          Molluscum Contagiousum

          Pelvic Inflammatory Disease (PID)

          Urinary Tract Infection

          Human Papillomavirus

          Acute Epididymitis

    Paragonimiasis

(New 2/11)

    Pertussis

(Revised 3/14)

    Plague

(Revised 9/12)

    Polio

(Updated 5/12)

    Psittacosis

(Updated 3/05)

    Q Fever

(Revised 2/08)

    Rabies

 

          Rabies, animal

(Revised 1/14)

          Rabies, human

(Revised 1/14)

    Ricin

(Updated 2/13)

    Rocky Mountain Spotted Fever

(Revised 4/08)

    Rubella

(Revised 11/13)

    Salmonellosis

(Revised 3/11)

    Shiga toxin-producing E. coli (STEC) and
    Shiga toxin positive, unknown organism

(Revised 6/11)

    Shigellosis

(Revised 3/11)

    Smallpox

(Revised 11/13)

    Streptococcus Disease

        Streptococcus Disease, invasive, Group A

(Revised 6/02)

        Streptococcus pneumoniae, drug-resistant invasive disease

(Revised 12/12)

        Streptococcus pneumoniae, invasive in children <5 years  

(Revised 12/12)

        Streptococcal Toxic Shock Syndrome

(Revised 6/00)

    Syphilis

(New 7/03)

    T-2 Mycotoxins

(New 8/03)

    Tetanus

(Revised 11/13)

    Toxic Shock Syndrome

(Revised 6/02)

    Trichinosis

(Updated 7/03)

    Tuberculosis Disease

(Revised 3/12)

    Tularemia

(Revised 4/09)

    Typhoid Fever

(Updated 7/03)

    Vaccinia, Adverse Reactions

(Revised 4/05)

    Vancomycin-Intermediate Staphylococcus aureus (VISA) and     Vancomycin-Resistant Staphylococcus aureus (VRSA)

(New 5/11)

    Varicella (Chickenpox)

(Revised 5/11)

    Vibriosis (non-cholera Vibrio species infections)

(New 11/12)

    West Nile Fever

(New 7/03)

    Yellow Fever

(Updated 7/03)

    Yersiniosis

(Revised 3/12)

    Appendices

(Revised 9/10)



Key

New

Recently added manual section.

Reviewed

Section content is current.

Revised

Section content:  may include reporting guidelines, forms, and intervention recommendations.

Updated

Web links, agency names and phone numbers.